Description

Key Benefits

• FELOCELL 3 is a non-adjuvanted modified-live virus (MLV) vaccine.
• Contains attenuated strains of feline rhinotracheitis virus, calicivirus, and panleukopenia virus (Johnson Snow Leopard strain), propagated on established cell lines.
• Safety of FELOCELL 3 was demonstrated in field trials involving 2,288 cats. No serious post-vaccination reactions attributable to the vaccine were reported.
• Packaged in freeze-dried form with inert gas in place of vacuum.
• Customer-friendly packaging includes peel-off labels for faster and more accurate record-keeping, a color-coded organizing system, and an easy-open safety band.
• FELOCELL 3 is supported by our Companion Animal Immunization Support Guarantee (ISG).

Dosage and Administration

1. General Directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL intramuscularly or subcutaneously.

2.  Primary Vaccination: Healthy cats 12 weeks of age or older should receive 2 doses administered 3-4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.

3. Revaccination: Annual revaccination with a single dose is recommended, although, as recommended by the American Veterinary Medical Association and its Council on Biologic and Therapeutic Agents, the attending veterinarian should determine the frequency of revaccination based on the animal's lifestyle and risk of exposure.*

*American Veterinary Medical Association, Position Statements on Biologics, June 2001.